Mesarect
Rectal suppositories for inflammatory bowel disease
Composition: Each suppository contains Mesalazine IP 1g
- First-line therapy for ulcerative proctitis
- Once a day dosage ensures compliance and convenience
- More effective than other dosage forms for relapsed patients
Indications: Inflammatory bowel disease
Dosage: 1g suppository once a day during bedtime for 3 to 6 weeks.
Packing: Carton containing 2 strips of 7 suppositories each.
Tagged carousel